Lenvima

Lenvima is a cancer medicine used to treat adults with: - differentiated thyroid carcinoma, a type of cancer originating from the follicular cells of the thyroid gland. Lenvima is used on its own when the cancer has progressed or spread locally or to other parts of the body, and does not respond to treatment with radioactive iodine; - hepatocellular carcinoma (a type of liver cancer). It is used on its own in patients who did not previously receive a cancer medicine by mouth or by injection and whose cancer is advanced or cannot be removed by surgery; - endometrial carcinoma (cancer of the lining of the womb). It is used together with another cancer medicine, pembrolizumab, in patients whose disease is advanced or has come back after previous treatment involving platinum-based cancer medicines, when surgery or radiation to cure the cancer is not possible. Lenvima contains the active substance lenvatinib.